Alector, Inc. Common Stock

ALECNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
1.64 USD
↘ 0.18 (9.67%)AT CLOSE (11:59 AM EDT)
1.72
↗ 0.08 (4.89%)
POST MARKET (AS OF 07:24 PM EDT)
Post Market
AS OF 07:24 PM EDT
1.72
↗ 0.08 (4.89%)
🔴Market: CLOSED
Open?$1.81
High?$1.84
Low?$1.63
Prev. Close?$1.81
Volume?364.4K
Avg. Volume?662.4K
VWAP?$1.68
Rel. Volume?0.55x
Bid / Ask
Bid?$1.37 × 100
Ask?$2.05 × 100
Spread?$0.68
Midpoint?$1.71
Valuation & Ratios
Market Cap?201.0M
Shares Out?111.0M
Float?83.0M
Float %?76.0%
P/E Ratio?N/A
P/B Ratio?19.36
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A

Shares of Alector, Inc. Common Stock (ALEC) are trading at $1.64. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
103
Market Cap
201.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.alector.com
Listed
2019-02-07
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-231-5660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
42
Piotroski F-Score?2/9Weak
Altman Z-Score?-6.21Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.85%Elevated
Short Interest?4.9M
Days to Cover?9.2
Free Float83.0M
Avg Daily Volume528.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?5.25Strong
Quick Ratio?5.25Strong
Cash Ratio?1.88Strong
Debt/Equity?0.94Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A▾
P/B?
Peers
100
S&P
8
19.36HIGH▾
P/S?
Peers
100
S&P
7
10.91HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.0CHEAP▾
EV/Sales?
Peers
100
S&P
19
7.26HIGH▾
Returns & Efficiency
ROE?
S&P
3
-1,210.3%WEAK▾
ROA?
S&P
3
-52.4%WEAK▾
Cash Flow & Enterprise
FCF?$-173200000
Enterprise Value?$133.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist